Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.3B | 14.8B | 14.7B | 13.6B |
Cost of revenue | 9.8B | 9.4B | 9.6B | 8.8B |
Gross profit | 5.5B | 5.4B | 5.1B | 4.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.3B | 2.3B | — | 1.9B |
Operating income | 2.7B | 2.5B | 4.6B | 2.4B |
Non operating interest income | ||||
Income | — | — | — | 39.6M |
Expense | 91.9M | 103.1M | 101.6M | 127.3M |
Other income expense | — | — | — | — |
Pretax income | 3.2B | 2.6B | 2.8B | 2.8B |
Tax provision | 714.5M | 695.9M | 793.7M | 725.4M |
Net income | 2.4B | 1.9B | 2.0B | 2.0B |
Basic EPS | — | 6.9 | 7.5 | 7.5 |
Diluted EPS | — | 6.8 | 7.5 | 7.5 |
Basic average shares | — | 271.4M | 271.3M | 271.1M |
Diluted average shares | — | 273.7M | 273.5M | 273.3M |
EBITDA | 3.8B | 3.3B | 3.1B | 3.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |